Racism is a public health crisis
Across the country, local and state leaders are declaring racism a public health crisis or emergency. These declarations are an important first step to…
Stay updated with breaking news from Reducing Mortality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Across the country, local and state leaders are declaring racism a public health crisis or emergency. These declarations are an important first step to…
2021-07-30 07:35:30 GMT2021-07-30 15:35:30(Beijing Time) Xinhua English BUENOS AIRES, July 30 (Xinhua) -- Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. "According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation globally," Jairo Mendez Rico, adviser on emerging viral diseases to the Pan American Health Organization (PAHO), told Xinhua recently. The WHO gave emergency-use approval to the COVID-19 v...
Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. "According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation globally," Jairo Mendez Rico, adviser on emerging viral diseases to the Pan American Health Organization (PAHO), told Xinhua recently. The WHO gave emergency-use approval to the COVID-19 vaccines developed by Chinese companies Sinopharm and Sinovac in May and June respectively. "We need to highlight ...
BUENOS AIRES (XINHUA) - The Covid-19 vaccine developed by Chinese pharmaceutical company Sinopharm is 84 per cent effective in preventing death from the disease, according to a report by the Argentine Ministry of Health. The document, titled "Study of the National Vaccination Campaign's Effectiveness in Reducing Mortality from Covid-19 in People aged 60 and over," was prepared by the ministry with cases from the country's 24 provinces during the period from Jan 1 to June 22. The study found that the Sinopharm vaccine has an efficacy of "84 per cent after the application of its two doses", sta...
2021-07-12 05:35:18 GMT2021-07-12 13:35:18(Beijing Time) Xinhua English BUENOS AIRES, July 11 (Xinhua) -- The COVID-19 vaccine developed by Chinese pharmaceutical company Sinopharm is 84 percent effective in preventing death from the disease, showed a report by the Argentine Ministry of Health. The document, titled "Study of the National Vaccination Campaign's Effectiveness in Reducing Mortality from COVID-19 in People aged 60 and over," was prepared by the ministry with cases from the country's 24 provinces during the period from Jan. 1 to June 22. The study found that the Sinopharm v...